CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection.
about
ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cellsiNKT Cells and Their Potential Lipid Ligands during Viral InfectionEBV promotes human CD8 NKT cell developmentMechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factorHuman natural killer T cells are heterogeneous in their capacity to reprogram their effector functionsIdentification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infectionSuppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signalsInnate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans.Invariant natural killer T (iNKT) cells in HAART-treated, HIV-positive patients with bone and cardiovascular impairment.Invariant NKT cells: regulation and function during viral infection.Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infectionSevere functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infectionLack of PD-L1 expression by iNKT cells improves the course of influenza A infection.NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionImpairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection.Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infectionIVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitisIdentification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosisAn alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cellsThe Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsNonrandom HIV-1 infection and double infection via direct and cell-mediated pathways.NKT cells and viral immunity.Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damagesTranscription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.HIV-1 Vpu interference with innate cell-mediated immune mechanisms.Immune pathogenesis of pediatric HIV-1 infection.Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvantsHIV Disrupts Human T Cells That Target Mycobacterial GlycolipidsImpact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.
P2860
Q21142651-C8075B87-5628-4915-998C-E6650A6473B4Q24802813-52AEFF2D-A862-44E0-981B-C999B6A1D89DQ26800120-CA566C33-6167-459F-8037-11C050A0B5DEQ27314724-51A00838-5ECB-45A8-A42C-0EB2D850DF32Q30448451-B1947A93-4222-4AA4-ABE1-0407F3B3A1EAQ33267309-7383BE3D-101D-42F4-85CD-C49F3F27BD4FQ33283061-E6AA4098-A1F6-4DEF-984D-AA3D005DAF7EQ33359540-C603ABBB-46CD-4618-BC3B-741B5A4ADAC9Q33390790-0BFD8004-456C-455D-9A66-47A1C9DD534CQ33547424-E1A527B0-C3C6-4D7A-9199-AE151212CC98Q33782527-3F0C42F2-2A6D-48E7-B1A8-24852677F1D2Q34150316-AE1EAD23-77B7-4202-A615-E2BD3D08D2B3Q34199154-137AA0FB-ED4A-43BA-B908-DA1C348523A5Q34361901-E42D5B1C-8E91-4718-86F1-90DE6DDE9C95Q34390484-39BE7DC1-5119-42E3-A428-A4BEA3D4C32FQ34426479-405B8F8D-A698-46B4-A625-8C01153F0D02Q34604276-E1E6A8BA-DF19-4A9E-9BF8-C5279502BDDDQ34649276-6676D41B-4C90-41A7-AD39-A799D72601C0Q34680046-EFC9E225-37E0-4CCC-8B09-10C54084C762Q34875335-650C968E-A35E-4CA4-9B5D-D8D989E15678Q34988967-B1286EB7-F8D6-4A7D-820A-D6221BBD3170Q35018213-204370DF-12B8-4CA9-B7BC-86511B967F0CQ35073712-03DBE242-EE85-4492-9482-BBC2A0D425DCQ35104944-2EB95681-7F1F-4F67-847E-DD7D7405BCB7Q35131643-66116084-6649-4659-B08A-53E2E556455BQ35139265-EA40C674-0512-488D-B68C-053FD3F41ACFQ35534748-9025EBEF-5433-4FFA-B847-78452938440FQ35600087-256A7428-76DC-4756-B567-F1920C6CE815Q35735892-6165D74D-4D67-4FD7-85A6-DB8552D51E8EQ35798179-A71DA721-479E-4474-B9F7-73B1D470F1C0Q35817615-10B4FDEB-C7E9-4B55-9C6C-18E6F15946E7Q35841871-2E51F663-5781-4A9B-8060-CA538D322649Q35847636-7DEAF3C1-E565-4FB5-8E75-89A13277D098Q35849560-5B80A90A-51CF-4E35-A76B-5B86796AEF97Q35978664-D0D5DDD4-698E-4AF4-9A65-1A47E414BBE6Q36141355-401BEF73-B69F-448D-8AB8-ED4F1F40B6E2Q36415769-860D8E17-E0B2-48BB-905E-CECBB17AE89BQ36474450-1FC55825-01E4-4D38-95EF-1A1FD333796FQ36487871-4D526425-1A61-47CD-BAB0-AE93D60CC54FQ36597496-D112151C-01D8-474B-B86A-DA1863976B13
P2860
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
CD1d-restricted human natural ...... odeficiency virus 1 infection.
@ast
CD1d-restricted human natural ...... odeficiency virus 1 infection.
@en
type
label
CD1d-restricted human natural ...... odeficiency virus 1 infection.
@ast
CD1d-restricted human natural ...... odeficiency virus 1 infection.
@en
prefLabel
CD1d-restricted human natural ...... odeficiency virus 1 infection.
@ast
CD1d-restricted human natural ...... odeficiency virus 1 infection.
@en
P2860
P50
P356
P1476
CD1d-restricted human natural ...... odeficiency virus 1 infection.
@en
P2093
David W Haas
Derya Unutmaz
P2860
P304
P356
10.1084/JEM.20011712
P407
P577
2002-04-01T00:00:00Z